After an allogeneic stem cell transplantation, the transferred immune cells are meant to fight remaining leukemia cells. However, they can also attack healthy tissue and trigger graft-versus-host disease (GvHD), most frequently in the gastrointestinal tract. A research team at Universitätsklinikum Regensburg, led by Elisabeth Meedt and Ernst Holler, has therefore examined IgA-producing plasma cells in the gut. The result: a loss of these cells was linked to severe GvHD and higher mortality, whereas high cell numbers were associated with an increased risk of relapse. The Wilhelm Sander-Stiftung funded the project with €194,000.

Office Munich

Wilhelm Sander-Stiftung
Zweigstraße 10
80336 Munich

Telephone: +49 89 544 187-0
E-Mail: info@sanst.de

Office Neustadtan der Donau

Wilhelm Sander-Stiftung
Herzog-Ludwig-Straße 17
93333 Neustadt an der Donau

Telephone: +49 9445 99199-0
E-Mail: neustadt@sanst.de

Office Leverkusen

Wilhelm Sander-Stiftung
Mülheimer Straße 76 a
51375 Leverkusen-Schlebusch

Telephone: +49 214 855 18-0
E-Mail: hv-leverkusen@sanst.de

Follow us on Linkedin


© 2026: Wilhelm Sander-Stiftung

Büro München

Wilhelm Sander-Stiftung
Zweigstraße 10
80336 München

Telefon: +49 89 544 187-0
E-Mail: info@sanst.de

Büro Neustadtan der Donau

Wilhelm Sander-Stiftung
Herzog-Ludwig-Straße 17
93333 Neustadt

Telefon: +49 9445 99199-0
E-Mail: neustadt@sanst.de

Büro Leverkusen

Wilhelm Sander-Stiftung
Mülheimer Straße 76 a
51375 Leverkusen-Schlebusch

Telefon: +49 214 855 18-0
E-Mail: hv-leverkusen@sanst.de


© 2026: Wilhelm Sander-Stiftung

Privacy Preference Center